DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
出版年份 2016 全文链接
标题
DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 115, Issue 10, Pages 1245-1252
出版商
Springer Nature
发表日期
2016-10-19
DOI
10.1038/bjc.2016.319
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) +/- nab-paclitaxel in patients with pancreatic cancer.
- (2016) Manuel Hidalgo et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma
- (2015) Liangjing Zhou et al. PATHOLOGY & ONCOLOGY RESEARCH
- A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors
- (2014) D. C. Smith et al. CLINICAL CANCER RESEARCH
- Notch1 Contributes to Chemoresistance to Gemcitabine and Serves as an Unfavorable Prognostic Indicator in Pancreatic Cancer
- (2013) Xiao Du et al. WORLD JOURNAL OF SURGERY
- Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer
- (2012) Muxing Kang et al. CANCER LETTERS
- Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells
- (2012) W.-C. Yen et al. CLINICAL CANCER RESEARCH
- Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma
- (2012) Christopher D. Mann et al. PLoS One
- High Expression of Delta-Like Ligand 4 Predicts Poor Prognosis After Curative Resection for Pancreatic Cancer
- (2011) Hai-Tao Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Blockade of Delta-Like Ligand 4 Signaling Inhibits Both Growth and Angiogenesis of Pancreatic Cancer
- (2010) Hidekazu Oishi et al. PANCREAS
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
- (2009) Timothy Hoey et al. Cell Stem Cell
- Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer
- (2009) M. E. Mullendore et al. CLINICAL CANCER RESEARCH
- Notch signaling regulates tumor angiogenesis by diverse mechanisms
- (2008) J Dufraine et al. ONCOGENE
- Notch signaling mediates hypoxia-induced tumor cell migration and invasion
- (2008) C. Sahlgren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started